How to Successfully Extend the Cash Runway to Growth in Early Commercial Stage Life Science Companies
By Andrew Levitch, Patrick Nugent
This article is the second in a 4-part series reviewing financing solutions for the Life Science sector. Life Science venture capital and private equity-funded startups are constantly chasing capital to extend operating cash runways, driving value inflection milestones such as clinical trial data and funding growth for commercial-stage entities. Understandably,…Read More
Read MoreTrends in Financing in Life Sciences: 2024 Updates
By Patrick Nugent
This article is first in a 4-part series reviewing financing solutions for the Life Science sector. As we move into Q2 of 2024, the Fed continues to hold the line on interest rate declines. Capital markets remain tight and for companies in need of growth financing, this is problematic. This…Read More
Read MorePlanning a Medical Device Business is Not for the Faint of Heart
By Greg Johnstone
Creating a business plan for a medical device company is a complex challenge, even for the most experienced founder and management team. A medical device business must contend with many of the same issues that face other technology-driven businesses. These include difficult engineering challenges, fundamental physical or biological constraints, complex…Read More
Read More2024 Trends & FLG Partners Celebrates 20 Years of Success
By Laureen DeBuono
In 2024, FLG Partners will celebrate our 20th Anniversary in business, thanks to the hundreds of clients, referral partners and industry colleagues who have helped us meet our objectives. Because of partnering with these colleagues, we have been able to close: 350+ M&A transactions 200+ IPOs 100+ Divestiture transactions And…Read More
Read More